When the first patient is dosed on IDX899, IDIX should receive about a quarter’s worth of cash, right?
My estimate is $10M—see #msg-45620605. The actual amounts of the IDX899 milestone payments will not be disclosed, although investors will be able to approximate these amounts ex post facto by scrutinizing the quarterly P&L statements.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”